Carl Zeiss Meditec Investor Relations

Carl Zeiss Meditec AG / Key word(s): Capital Increase/Corporate Action22-March-2017 / 08:12 CET/CESTDisclosure of an inside information acc. DGAP-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution DGAP Voting Rights. Nach starken Jahresendergebnissen hat die Carl Zeiss Meditec AG auch im ersten Quartal 2017/18 ihren Wachstumstrend fortgesetzt. 65% are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries. Jena/Germany, 13. 7 percent), to €926. Müller shall be responsible for the areas of finance, investor relations and IT. In his new role as a member of the Management Board and CFO of Carl Zeiss Meditec, Dr. 1 percent (adjusted for currency effects, 11. Carl Zeiss Meditec AG Recruits James V. Investors Renishaw is a world leading metrology company. *Continued profitable growth for Carl Zeiss Meditec* *Successful first half - company provides new outlook for FY 2018/19* JENA, May 6, 2019 *In the first half of fiscal year 2018/19 Carl Zeiss Meditec generated revenue of EUR667. Carl Zeiss Meditec AG / Quarterly report / Ad hoc: Carl Zeiss Meditec achieved sales growth in the first six months of the financial year 2012/2013 of around 3%. It was founded by Ernst Abbe in 1889 and named after his long-term partner Carl Zeiss. Sebastian Frericks - Director of Investor Relations. "At Zeiss, we are committed to providing the highest level of product quality. [email protected] Carl Zeiss Meditec AG erzielt Umsatzwachstum von rund 7% in den ersten neun Monaten 2017/18 und passt Umsatzprognose an: Jena, 3. Management, Strategie, Investor Relations und Unternehmenskultur der CSM Aktie. Carl Zeiss Meditec announced the introduction of the Humphrey(R) Matrix, the latest innovation in visual field testing and management. Informa Markets - Healthcare, in charge of the healthcare portfolio within Informa's Global Exhibitions division, organises several exhibitions yearly covering the Middle East, Africa, Asia, Europe and US market, connecting more than 230,000 healthcare professionals worldwide and offering a range of marketing solutions for companies involved with the. Henriette has 3 jobs listed on their profile. Sirona und Carl Zeiss Meditec kooperieren bei der Ausstattung von Universitätszahnkliniken Beide Unternehmen bieten integrierte Spitzentechnologie für die Zahnärzte von morgen. Carl Zeiss Meditec est spécialisé dans la production et la commercialisation de systèmes et de matériels de diagnostic ophtalmologique. Bekijk het profiel van Clara Kries op LinkedIn, de grootste professionele community ter wereld. With its head-quarters in Jena (Germany) and additional plants and subsidiaries in Germany, France, Spain, the USA and Japan, the Company has a direct presence in the world's most important medical technology markets. ZEISS Medical Technology Segment of ZEISS announced that it has received 510(k) clearance from the FDA for the CIRRUS HD-OCT platform, expanding the capabilities of its Anterior Segment Premier Module to include Epithelial Thickness Mapping (ETM). The ZEISS Group has announced three new appointments Effective 1 October 2018, Dr. Carl Zeiss Meditec wird von Dr. They also assigned media coverage about the company a news buzz of 0. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. Carl Zeiss Meditec AG Announces New CFO and Expansion of the Management Board - Nachrichtendetails | Börse München skip to content Javascript must be enabled for correct page display. The company was founded in 2002 and is headquartered in Jena, Germany. E-Mail: investors. JENA, 21 March 2017. The medical technology portfolio of Carl Zeiss Meditec is rounded off by promising, future-oriented technologies such as intraoperative radiotherapy. Carl Zeiss Meditec AG (AFXX:GER) financials, including income statements, growth rates, balance sheets and cash flow information. Christian Müller werde zum 15. Revenue increased by 9. 9 percent (prior year: 12. View Henriette Meyer's profile on LinkedIn, the world's largest professional community. We welcome you to Carl Zeiss Meditec AG's Investor Relations website and thank you for your interest in our company. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. Check the job post at ZEISS CAREER webside:. Monday, December 14, 2009 12:27 AM JENA, Germany—Dr. Carl Zeiss Meditec shares are in free float. DE) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and. Henriette has 3 jobs listed on their profile. Description: Carl Zeiss Meditec AG is a Jena, Germany-based manufacturer of ophthalmic devices, such as intraocular lenses, diagnostic equipment, and refractive laser systems, along with optical equipment for microsurgical applications such as neurosurgery. Müller shall be responsible for the areas of finance, investor relations and IT. Erfahren Sie mehr über die Kontakte von Clara Kries und über Jobs bei ähnlichen Unternehmen. Carl Zeiss Meditec's pays a lower dividend yield than the bottom 25% of dividend payers in Germany (1. The Carl Zeiss Meditec Group has operations all over the world. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Dabei setzen wir unverändert auf organisches Wachstum, das durch gezielte Zukäufe ergänzt werden soll. Gross proceeds amount to approximately EUR 317 million. Erfahren Sie mehr zu den Bewertungen für Carl Zeiss Meditec AG in Berlin auf werkenntdenBESTEN. Sehen Sie sich das Profil von Clara Kries auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. JENA, Germany — Carl Zeiss Meditec AG announced its new supervisory board earlier this week. If you already have an account, please login first. Carl Zeiss Meditec AG resolves on a cash capital increase of up to 10 percent. Find a variety of Carl Zeiss Meditec AG statistics including live AFX. Financial. Carl Zeiss Meditec's pays a lower dividend yield than the bottom 25% of dividend payers in Germany (1. Sebastian Frericks - Director of Investor Relations. Head of Ophthalmic Devices Global Communications at Carl Zeiss Meditec AG sales operations, investor relations, marketing strategy and event planning. EBIT margin rose further year-on-year. The All-New Robotic Visualization System KINEVO 900 From Carl Zeiss Meditec AG Revolutionizes Neurosurgical Visualization - read this article along with other careers information, tips and advice on BioSpace. comAsia PacificLevel 462 Park StreetSydney,. EDFA assembly,. The company now reports in two primary segments, ophthalmic devices (73% of fiscal 2018. The ZEISS Group has announced three new appointments Effective 1 October 2018, Dr. Carl Zeiss offers innovative solutions for the future-oriented markets of Medical and Research Solutions, Industrial Solutions and Lifestyle Products. Müller will succeed Bernd Hirsch, who left the company at his own request on Nov. DEWB sold its 9. Gross proceeds amount to approximately EUR 317 million. The Ophthalmic Devices segment includes intraocular lenses, surgical visualization solutions, and medical laser and diagnostic systems. Press contact: Jann Gerrit Ohlendorf, Group Communications, Carl Zeiss Meditec AG Phone +49 (0) 3641 220-331, Email: press. About Carl Zeiss Meditec AG. [email protected] The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Carl Zeiss Meditec AG Announces New CFO and Expansion of the Management Board - Nachrichtendetails | Börse München skip to content Javascript must be enabled for correct page display. Jun 03, 2019 · DGAP-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution DGAP Voting Rights. Carl Zeiss Meditec AG has successfully completed a cash capital increase from authorized capital. En outre, le groupe fabrique et vend des systèmes de. Carl Zeiss-Stand auf der IDS: Halle 10. 7 percent (adjusted for currency effects: +6. To ensure the highest possible level of transparency, this website provides comprehensive and detailed information about our IR activities and the performance of Carl Zeiss Meditec. Contact for investors and press Sebastian Frericks Director Investor Relations Carl Zeiss Meditec AG Tel. Pozostałe 65 procent jest w posiadaniu Carl Zeiss AG, jednym z wiodących na świecie grup w optycznym i optoelektronicznym przemyśle. Contact for investors and press Sebastian Frericks Director Investor Relations Carl Zeiss Meditec AG Tel. This increase of 40. 7 percent (adjusted for currency effects: +6. To ensure the highest possible level of transparency, this website provides comprehensive and detailed information on our IR activities and the performance of the Carl Zeiss Meditec Group. 8 percent; prior year's. Stay alerted to dividend announcements for CZMWF and all the companies you follow at NASDAQ. View Sebastian Frericks’s professional profile on Relationship Science, the database of decision makers. Müller will succeed Bernd Hirsch, who left the company at his own request on Nov. Um ein Höchstmaß an Transparenz zu gewähren, stellt diese Website umfassende Informationen über die Unternehmensentwicklung der Carl Zeiss Meditec Gruppe und unsere IR-Aktivitäten zur Verfügung. Carl Zeiss Meditec AG (AFXX:GER) financials, including income statements, growth rates, balance sheets and cash flow information. Carl Zeiss Meditec AG has successfully completed a cash capital increase from authorized capital. 028 BILLION EUR. The remaining approx. 9M REVENUE 1. Brief profile Carl Zeiss Meditec AG: Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX of the German stock exchange, is one of the world's leading medical technology companies. DGAP-News: Carl Zeiss Meditec AG / Key word(s): Final Results Carl Zeiss Meditec AG grows by about 9% in fiscal year 2016/17 08. DGAP-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution DGAP Voting Rights. Vizualizaţi profilul Kim Nguyen pe LinkedIn, cea mai mare comunitate profesională din lume. He was Deputy Chairman of the Supervisory Board of Carl Zeiss Meditec AG from January 22, 2018. Carl Zeiss offers innovative solutions for the future-oriented markets Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics. Carl Zeiss Meditec generated revenue of EUR1,027. Carl Zeiss Meditec reports revenue growth of 3. Carl Zeiss Meditec AG Announces New CFO and Expansion of the Management Board - Nachrichtendetails | Börse München skip to content Javascript must be enabled for correct page display. (1) ReLEx is a new application that allows ophthalmic surgeons to perform a variety of complete laser vision correction procedures using only the VisuMax® Femtosecond laser. Financial. So sehen Analysten die Carl Zeiss Meditec-Aktie. FE Investegate announcements from Carl Zeiss Meditec AG, OPMI LUMERA 700 from Carl Zeiss Meditec Receive. JENA, 11 May 2016 Medical technology company Carl Zeiss Meditec AG increased its revenue by 8. The six months 2018/19 financial report will be published on May 6, 2019. Herzlich willkommen auf der Investor Relations Seite der Carl Zeiss Meditec AG. View Kay DeMonge's profile on LinkedIn, the world's largest professional community. The company now reports in two primary segments, ophthalmic devices (73% of fiscal 2018. 2m, representing an increase of 8. The head office of Carl Zeiss Meditec is in Jena, Germany. Carl Zeiss Meditec Recruits James V. W przeciwieństwie do oświadczenia złożonego we wcześniejszym komunikacie prasowym przez PhysIOL SA w toku postępowania, PhysIOL SA uznała prawa własności intelektualnej Carl Zeiss Meditec AG i zaakceptowała zawarcie umowy z Carl Zeiss Meditec AG. We welcome you to Carl Zeiss Meditec AG's Investor Relations website and thank you for your interest in our company. We welcome you to Carl Zeiss Meditec´s Investor Relations website and thank you for your interest in our company. 7 percent), to €926. Due in particular to the positive development of revenue, the improved product mix and the increased proportion of recurring revenue, Carl Zeiss Meditec AG anticipates an adjusted EBIT margin of between 14% and 16% in fiscal year 2017/18 and in the medium term. In the first half of fiscal year 2018/19 Carl Zeiss Meditec generated revenue of EUR667. Laurie Ferguson liked this. DE) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and. : +49 7364 20-6756 Fax: +49 7364 20-5612 press. The head office of Carl Zeiss Meditec is in Jena, Germany. PRESS RELEASE: Carl Zeiss Meditec AG: Carl Zeiss Meditec looks back on a successful financial year | aktiencheck. Carl Zeiss Meditec Vertriebsgesellschaft mbH in Jena, reviews by real people. Sehen Sie sich das Profil von Clara Kries auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. They can be contacted via phone at (925) 577-4100 for pricing, hours and directions. Christian Müller, current CFO of Carl Zeiss Meditec AG, to become CFO of Carl Zeiss AG; Justus Felix Wehmer to assume the role of CFO at Carl Zeiss Meditec AG; Expansion of the Management Board at Carl Zeiss Meditec AG with appointment […]. Search for a market's symbol or name (AAPL or Apple) or an investor's name. [email protected] 9 percent (prior year: 12. DE) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and. Carl Zeiss Meditec AG Head of Marketing Communications Tel. Yelp is a fun and easy way to find, recommend and talk about what's great and not so great in Jena and beyond. With over 20 years of global M&A, financing, and alliance activity - Strategic Transactions is the premium source that top pharmaceutical firms, PLUS leaders in medical devices, diagnostics, finance, and consulting turn to for the best available. ZEISS presents the new IOLMaster 700 for better predictability and optimized workflows in cataract surgery The IOLMaster ® 700 with SWEPT Source Biometry™ enables physicians to identify irregular geometries of their patients eyes at an early stage. Gross proceeds amount to approximately EUR 317 million. Investor relations; Carl Zeiss Meditec has strengthened its cataract surgical offering by acquiring an intelligent cloud-based data management platform to. The remaining approx. View News Stories for Carl Zeiss Meditec. Sirona und Carl Zeiss Meditec kooperieren bei der Ausstattung von Universitätszahnkliniken Beide Unternehmen bieten integrierte Spitzentechnologie für die Zahnärzte von morgen. 8% for 9M 2013/14 - EBIT close to previous year's level - EPS decline by 13%. View Henriette Meyer's profile on LinkedIn, the world's largest professional community. 8 million; earnings before interest and taxes (EBIT) also increased to EUR 75 million (prior year: EUR 61 million), corresponding to an EBIT margin of 13. Découvrez le profil de Kim Nguyen sur LinkedIn, la plus grande communauté professionnelle au monde. Description: Carl Zeiss Meditec AG is a Jena, Germany-based manufacturer of ophthalmic devices, such as intraocular lenses, diagnostic equipment, and refractive laser systems, along with optical equipment for microsurgical applications such as neurosurgery. Revenue increased by 9. Consultez le profil complet sur LinkedIn et découvrez les relations de Jeremy, ainsi que des emplois dans des entreprises similaires. 1 percent (adjusted for currency effects, 11. About Informa Markets - Healthcare. 2% is mainly due to the first-time inclusion of Acri. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG. Carl Zeiss Meditec is directly represented in USA, Japan, Germany, Spain and France with its own subsidiaries in these countries. DEWB, the listed German firm that recently took over Swiss investment group optic, has sold one of its existing investments in ophthalmic systems provider, Carl Zeiss Meditec. 2018 / 16:06 Carl Zeiss Meditec AG Carl Zeiss Meditec AG Announces New CFO and Expansion of the Management BoardEffective 1 October 2018,. Sebastian Frericks, Investor Relations, Carl Zeiss Meditec AG Telefon +49 (0) 3641 220-116, Email: investors. Business report. Sehen Sie sich auf LinkedIn das vollständige Profil an. In addition, the Carl Zeiss Meditec Group. The Carl Zeiss Meditec Group has operations all over the world. Revenue increased by 9. [email protected] ARCHIV; Director Investor Relations, Carl Zeiss Meditec AG. A total of. [i] ReLEx is a new application that allows ophthalmic surgeons to perform. 8 percent; prior year's. Over 350 of them staff the head office of Carl Zeiss Meditec AG in Jena. He was Member of the Supervisory Board at Carl Zeiss Meditec AG from April 12, 2011. 2018 / 16:06 Carl Zeiss Meditec AG Carl Zeiss Meditec AG Announces New CFO and Expansion of the Management BoardEffective 1 October 2018,. Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX of the German stock exchange, is one of the world's leading medical technology companies. Mit Firmensitz in Jena sowie. The remaining approx. , Dublin USA, and Insight Photonics Solutions, Inc. 0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. To ensure the highest possible level of transparency, this website provides comprehensive and detailed information about our IR activities and the performance of Carl Zeiss Meditec. Welcome to HELLA Investor Relations. Unternehmensstandorte der Carl Zeiss Meditec Gruppe Produktion, Vertrieb, Service, F&E Vertriebs-und Servicestandorte der Carl Zeiss Meditec Gruppe USA, Frankreich, Spanien, Deutschland, Japan, Türkei Vertriebs-und Servicestandorte der ZEISS Gruppe Die Carl Zeiss Meditec Gruppe ist weltweit präsent. [email protected] 9 percent (prior year: 12. Director Investor Relations Carl Zeiss Meditec AG Phone: +49 3641 220-116 Fax: investors. The remaining approx. Carl Zeiss Meditec's medical technology portfolio is rounded off by promising future technologies such as intraoperative radiation therapy. 3m (prior year: €864. The issuer is solely responsible for the content of this announcement. Carl Zeiss Meditec Inc has an annual sales volume of 501K - 999,999. In total up to 8,130,960 new shares will be offered to. 3%, to EUR1,189. 8 percent; prior year's. So sehen Analysten die Carl Zeiss Meditec-Aktie. 9M REVENUE 1. Carl Zeiss Meditec records positive first quarter Revenue up four per cent, Investor Relations, Carl Zeiss Meditec AG Phone 03641 220-106, E-Mail: investors. 03641 220-116 E-Mail: investors. ZEISS presents the new IOLMaster 700 for better predictability and optimized workflows in cataract surgery The IOLMaster ® 700 with SWEPT Source Biometry™ enables physicians to identify irregular geometries of their patients eyes at an early stage. 9%) compared with the. View Michael Romano’s profile on LinkedIn, the world's largest professional community. Carl Zeiss Meditec AG. [email protected] Business report. *Continued profitable growth for Carl Zeiss Meditec* *Successful first half - company provides new outlook for FY 2018/19* JENA, May 6, 2019 *In the first half of fiscal year 2018/19 Carl Zeiss Meditec generated revenue of EUR667. Vielen Dank für Ihr Interesse an unserem Unternehmen. com Carl Zeiss AG. DE stock quotes, market price charts, market cap, and everything you need to know to invest in AFX. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their. 028 BILLION EUR. Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX of the German stock exchange, is one of the world's leading medical technology companies. Explore commentary on Carl Zeiss Meditec AG and hear what the experts at. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. Contact for investors and press Sebastian Frericks Director Investor Relations Carl Zeiss Meditec AG Tel. Carl Zeiss Meditec earned a news sentiment score of -2. Carl Zeiss Meditec AG (OTC:CZMWY) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Sellbyville, DE -- (SBWIRE) -- 05/06/2019 -- The Ophthalmic Viscosurgical Devices Market is set to exceed USD 790 million by 2024; according to a new research report by Global Market Insights. 7 percent (adjusted for currency effects: +6. 3m (prior year: €864. A Goodwill is an intangible asset that arises as a result of the acquisition of one company by another for a premium value. Over 350 of them staff the head office of Carl Zeiss Meditec AG in Jena. Carl Zeiss Meditec AG est l'un fournisseurs de premier ordre dans le domaine de la technologie médicale. Gross proceeds amount to approximately EUR 317 million. View detailed financial information, real-time news, videos, quotes and analysis on CARL ZEISS MEDITEC AG (OTC:CZMWY). Henriette Meyer is Senior Manager-Investor Relations at Carl Zeiss Meditec AG. Business report. Carl Zeiss Meditec announced the introduction of the Humphrey(R) Matrix, the latest innovation in visual field testing and management. de einsehbar. View Kay DeMonge's profile on LinkedIn, the world's largest professional community. Carl Zeiss Meditec AG Head of Marketing Communications Tel. Revenue increased by 9. com [1] Das währungsbereinigte Umsatzwachstum wird ermittelt, indem der Umsatz der Vergleichsperiode (Vorjahr) mit aktuellen Wechselkursen umgerechnet wird. Sehen Sie sich das Profil von Clara Kries auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. [email protected] Description: Carl Zeiss Meditec AG is a Jena, Germany-based manufacturer of ophthalmic devices, such as intraocular lenses, diagnostic equipment, and refractive laser systems, along with optical equipment for microsurgical applications such as neurosurgery. Carl Zeiss Meditec AG Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX and SDax of the German stock exchange, is one of the world's leading medical technology companies. DEWB sold its 9. Henriette has 3 jobs listed on their profile. Key Personnel: Michael Kaschke, president & CEO; Thomas Spitzenpfeil, CFO; Matthias Metz, president & CEO, Carl Zeiss Vision International; Ludwin Monz, president. Christian Müller, current CFO of Carl Zeiss Meditec AG, to become CFO of Carl Zeiss AG; Justus Felix Wehmer to assume the role of CFO at Carl Zeiss Meditec AG; Expansion of the Management Board at Carl Zeiss Meditec AG with appointment […]. With over 20 years of global M&A, financing, and alliance activity – Strategic Transactions is the premium source that top pharmaceutical firms, PLUS leaders in medical devices, diagnostics, finance, and consulting turn to for the best available. Jena - Das Medizintechnikunternehmen Carl Zeiss Meditec Börsen-Chart zeigen hat den vakanten Posten des Finanzvorstands intern vergeben. Herzlich willkommen auf der Investor Relations Seite von Carl Zeiss Meditec. JENA, 21 March 2017. Latest surgical microscope for the ophthalmic surgeon impresses not only users, but also designers. Sehen Sie sich auf LinkedIn das vollständige Profil an. 8 percent; prior year's. Corporate Governance. : +49 3641 220-116 E-Mail: investors. 5m (prior year: EUR540. Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX of the German stock exchange, is one of the world’s leading medical technology companies. Mit Firmensitz in Jena sowie. The All-New Robotic Visualization System KINEVO 900 From Carl Zeiss Meditec AG Revolutionizes Neurosurgical Visualization - read this article along with other careers information, tips and advice on BioSpace. Jena/Germany, 13. Kim indique 3 postes sur son profil. Gross proceeds amount to approximately EUR 317 million. Sebastian Frericks, Investor-Relations-Chef beim deutschen Medizintechnikhersteller, habe eine sehr informative Präsenta. [email protected] Strong demand for capital increase Carl Zeiss Meditec AG raises proceeds of around EUR 317 million from the capital increase. See the company profile for CARL ZEISS MEDITEC AG (AFX. Vielen Dank für Ihr Interesse an unserem Unternehmen. 's business for stockholders, potential investors, and financial analysts. ZEISS Medical Technology Segment of ZEISS announced that it has received 510(k) clearance from the FDA for the CIRRUS HD-OCT platform, expanding the capabilities of its Anterior Segment Premier Module to include Epithelial Thickness Mapping (ETM). With its head-quarters in Jena (Germany) and additional plants and subsidiaries in Germany, France, Spain, the USA and Japan, the Company has a direct presence in the world’s most important medical technology markets. Carl Zeiss offers innovative solutions for the future-oriented markets Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics. 0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. With over 20 years of global M&A, financing, and alliance activity – Strategic Transactions is the premium source that top pharmaceutical firms, PLUS leaders in medical devices, diagnostics, finance, and consulting turn to for the best available. Director Investor Relations Carl Zeiss Meditec AG Phone: +49 3641 220-116 Fax: investors. Carl Zeiss Meditec zielt für das laufende Geschäftsjahr auf oberen Rand der Director Investor Relations Carl Zeiss Meditec AG Tel. de DJ Carl Zeiss Meditec AG reaffirms its annual target | aktiencheck. EARNINGS BEFORE. EUR und legte damit um 10,9% (währungsbereinigt: +8,9%) im Vergleich zur. Carl Zeiss Meditec AG, which is listed on TecDAX of the German stock exchange, is one of the world's leading medical technology companies. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. View Michael Romano's profile on LinkedIn, the world's largest professional community. Advanced trading tools. Sebastian Frericks, Investor Relations, Carl Zeiss Meditec AG Telefon +49 (0) 3641 220-116, Email: investors. DGAP Voting Rights Announcement: Carl Zeiss Meditec AG Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 03. Carl Zeiss Meditec's pays a lower dividend yield than the bottom 25% of dividend payers in Germany (1. It was founded by Ernst Abbe in 1889 and named after his long-term partner Carl Zeiss. Carl Zeiss Meditec AG (OTC:CZMWY) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. EARNINGS BEFORE. 7 percent), to €926. Monday, December 14, 2009 12:27 AM JENA, Germany—Dr. Carl Zeiss-Stand auf der IDS: Halle 10. DGAP-News: Carl Zeiss Meditec AG / Key word(s): Quarterly / Interim Statement/Quarter Results Carl Zeiss Meditec AG starts new fiscal year 2017/18 with solid. Christian Müller is to be appointed as a new member of the management board and chief financial officer of Carl Zeiss Meditec AG, effective Dec. DE Share CFD Trading with Plus500™. Carl Zeiss Meditec rémunérera 80% du bloc de contrôle en espèces et 20% par l’émission d’actions nouvelles Carl Zeiss Meditec. announced shipment of its 1,000th OPMI Pentero Surgical Microscope since its worldwide market launch three years ago. E-Mail: investors. 内容提示: Carl Zeiss Meditec AGCompany ProfilePublication Date: 3 Nov 2011www. Ad Hoc Announcement 18-Jul-2014. Carl Zeiss Meditec's pays a lower dividend yield than the bottom 25% of dividend payers in Germany (1. For complete information on the function, structure and risks and opportunities of the security, potential investors should read the Prospectus, which contains the Base Prospects , Supplements and Final Terms, carefully before making any investment decision. [i] ReLEx is a new application that allows ophthalmic surgeons to perform. For more information, please go to: www. Carl Zeiss Meditec earned a news sentiment score of -2. 9% (adjusted for currency effects: +8. The new company is the result of a merger between Carl Zeiss Ophthalmic and Aesculap-Meditec. ZEISS presents the new IOLMaster 700 for better predictability and optimized workflows in cataract surgery The IOLMaster ® 700 with SWEPT Source Biometry™ enables physicians to identify irregular geometries of their patients eyes at an early stage. With over 20 years of global M&A, financing, and alliance activity - Strategic Transactions is the premium source that top pharmaceutical firms, PLUS leaders in medical devices, diagnostics, finance, and consulting turn to for the best available. Markus Hammann Head of Digital Solutions Sales and Marketing Germany bei Carl Zeiss Meditec AG Jena, Thüringen, Deutschland Medizintechnik. Industry Relations Sales Executive Carl Zeiss Meditec, Inc. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. Carl Zeiss Meditec (PC) stock quote and CZMWF charts. Carl Zeiss Meditec has achieved preliminary FY 2013/14 revenue near the low end of forecast range – EBIT and EPS expected below the high previous year’s level. View Sebastian Frericks’s professional profile on Relationship Science, the database of decision makers. Barbara Williams Customer Service Representative at Carl Zeiss Meditec, Inc. DEWB, the listed German firm that recently took over Swiss investment group optic, has sold one of its existing investments in ophthalmic systems provider, Carl Zeiss Meditec. EDFA assembly,. Bekijk het volledige profiel op LinkedIn om de connecties van Clara Kries en vacatures bij vergelijkbare bedrijven te zien. Carl Zeiss Meditec AG / Carl Zeiss Meditec AG : Carl Zeiss Meditec improves its results in first six months of financial year 2012/2013. The Ophthalmic Devices segment includes intraocular lenses, surgical visualization solutions, and medical laser and diagnostic systems. ist in der Aktie noch mehr drin, weshalb wir einsteigen. To ensure the highest possible level of transparency, this website provides comprehensive and detailed information about our IR activities and the performance of Carl Zeiss Meditec. Christian Müller is to be appointed as a new member of the management board and chief financial officer of Carl Zeiss Meditec AG, effective Dec. Over 350 of them staff the head office of Carl Zeiss Meditec AG in Jena. Vizualizaţi profilul Kim Nguyen pe LinkedIn, cea mai mare comunitate profesională din lume. The company was founded in 2002 and is headquartered in Jena, Germany. Sebastian Frericks is Director:Investor Relations at Carl Zeiss Meditec AG. Januar 2013 - Mai 2016 3 Jahre 5 Monate. DE Share CFD Trading with Plus500™. Oktober 2018 mit Justus Felix Wehmer (53), der derzeit CFO und Co-Leiter des Unternehmensbereichs Microscopy der Zeiss Gruppe ist, zu besetzen. DE) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and. Carl Zeiss Meditec AG (OTCPK:CZMWY) Nine Months 2018 Earnings Conference Call August 10, 2017 3:30 AM ET Executives Sebastian Frericks – Director Investor Relations Ludwin Monz – President and. 9% (adjusted for currency effects: +8. EUR und legte damit um 10,9% (währungsbereinigt: +8,9%) im Vergleich zur. After nine months 2017/18, Carl Zeiss Meditec AG was able to achieve further encouraging growth in all strategic business units and regions: Revenue increased by 7. Carl Zeiss offers innovative solutions for the future-oriented markets Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics. Die Aktie von Carl Zeiss Meditec wird von mehreren Analysten beobachtet. ZEISS Introduces OPMI PENTERO 800 to Reconstructive Surgery Investor Relations, Carl Zeiss Meditec AG, Phone +49(0)3641-220-116, ZEISS Introduces OPMI PENTERO 800 to Reconstructive Surgery. View News Stories for Carl Zeiss Meditec. Contact for investors and press Sebastian Frericks Director Investor Relations Carl Zeiss Meditec AG Tel. Sebastian Frericks - Director of Investor Relations. ARCHIV; Director Investor Relations, Carl Zeiss Meditec AG. 1 percent (adjusted for currency effects, 11. 2017 / 07:00 The issuer is. Müller will succeed Bernd Hirsch, who left the company at his own request on Nov. With its head-quarters in Jena (Germany) and additional plants and subsidiaries in Germany, France, Spain, the USA and Japan, the Company has a direct presence in the world's most important medical technology markets. So sehen Analysten die Carl Zeiss Meditec-Aktie. Vorstand der Carl Zeiss Meditec AG wird erweitert. : +49 3641 220-116 E-Mail: investors. *Continued profitable growth for Carl Zeiss Meditec* *Successful first half - company provides new outlook for FY 2018/19* JENA, May 6, 2019 *In the first half of fiscal year 2018/19 Carl Zeiss Meditec generated revenue of EUR667. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients.